⚠ Evidence note: Most trends in this area rest on anecdote and mechanism; where real evidence exists it is usually for narrower claims than the trend makes.
Engineered Exosomes
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-10-01 — Endothelial TLR4 at the Crossroads of Vascular Senescence and Targeted Senotherapeutics.: cross-connection with precision-geromedicine-protocols: Review proposes engineered plant exosomes as an endothelium-targeted delivery vehicle for TLR4-directed senotherapeutics, linking the precision-geromedicine framing to the engineered-exosome delivery platform. (novelty: 3)
- 2026-09-23 — Engineered Extracellular Vesicle Revitalizing Macrophage Energy Metabolism for Aged Wound Repair.: cross-connection with engineered-extracellular-vesicles: Both track engineered vesicle payloads as regenerative modalities; the 4OI-EV wound-repair work sits at the metabolic-reprogramming edge of the broader engineered-exosome trend. (novelty: 3)
- 2026-09-15 — Reprogramming the Aging Type H Vascular Niche via Myeloid Angiogenic Cell-Derived Extracellular Vesicles: Mechanisms, Engineering Strategies, and Translational Perspectives.: Review synthesizes engineering strategies (donor preconditioning, cargo loading, surface targeting, scaffold-based delivery) intended to overcome senescence-associated liabilities of endothelial-lineage EVs; framework paper, not an outcome study. [expert-opinion] (novelty: 3)
Open questions
Related
Contributing findings
Reprogramming the Aging Type H Vascular Niche via Myeloid Angiogenic Cell-Derived Extracellular Vesicles: Mechanisms, Engineering Strategies, and Translational Perspectives.
15-sep-2026
novelty 3
per-area 3
strengthens
Engineered Exosomes as a Treatment for Alzheimer's Disease
07-sep-2026
novelty 2
per-area 3
introduces